Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
|
|
Karyopharm Therapeutics Inc. (KPTI)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/05/2023 |
4
| Paulson Richard A. (President and CEO) has filed a Form 4 on Karyopharm Therapeutics Inc.|
Txns:
| Sold 3,589 shares
@ $1.27, valued at
$4.6k
|
|
| 08/08/2023 |
4
| Paulson Richard A. (President and CEO) has filed a Form 4 on Karyopharm Therapeutics Inc.|
Txns:
| Sold 3,722 shares
@ $1.72, valued at
$6.4k
|
|
| 08/02/2023 |
S-8
| Form S-8 - Securities to be offered to employees in employee benefit plans: |
| 08/02/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 08/02/2023 |
8-K
| Quarterly results |
| 08/01/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/10/2023 |
SC 13G/A
| STATE STREET CORP reports a 1.9% stake in EXIT FILING KARYOPHARM THERAPEUTICS INC |
| 07/06/2023 |
4
| Paulson Richard A. (President and CEO) has filed a Form 4 on Karyopharm Therapeutics Inc.|
Txns:
| Sold 3,538 shares
@ $1.72, valued at
$6.1k
|
|
| 06/12/2023 |
4
| Cheng Sohanya Roshan (EVP & Chief Commercial Officer) has filed a Form 4 on Karyopharm Therapeutics Inc.|
Txns:
| Sold 1,839 shares
@ $2.35, valued at
$4.3k
|
|
| 06/07/2023 |
4
| Paulson Richard A. (President and CEO) has filed a Form 4 on Karyopharm Therapeutics Inc.|
Txns:
| Sold 3,536 shares
@ $2.2404, valued at
$7.9k
|
|
| 05/25/2023 |
4
| Schor Chen (Director) has filed a Form 4 on Karyopharm Therapeutics Inc.|
Txns:
| Granted 34,000 options to buy
@ $2.5, valued at
$85k
|
|
| 05/25/2023 |
4
| PAKIANATHAN DEEPIKA (Director) has filed a Form 4 on Karyopharm Therapeutics Inc.|
Txns:
| Granted 34,000 options to buy
@ $2.5, valued at
$85k
|
|
| 05/25/2023 |
4
| Oliger Christy J. (Director) has filed a Form 4 on Karyopharm Therapeutics Inc.|
Txns:
| Granted 34,000 options to buy
@ $2.5, valued at
$85k
|
|
| 05/25/2023 |
4
| Mirza Mansoor Raza (Director) has filed a Form 4 on Karyopharm Therapeutics Inc.|
Txns:
| Granted 34,000 options to buy
@ $2.5, valued at
$85k
|
|
| 05/25/2023 |
4
| Honig Peter (Director) has filed a Form 4 on Karyopharm Therapeutics Inc.|
Txns:
| Granted 34,000 options to buy
@ $2.5, valued at
$85k
|
|
| 05/25/2023 |
4
| BOHLIN GAREN G (Director) has filed a Form 4 on Karyopharm Therapeutics Inc.|
Txns:
| Granted 34,000 options to buy
@ $2.5, valued at
$85k
|
|
| 05/25/2023 |
4
| Greene Barry E (Director) has filed a Form 4 on Karyopharm Therapeutics Inc.|
Txns:
| Granted 34,000 options to buy
@ $2.5, valued at
$85k
|
|
| 05/25/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 05/08/2023 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 05/05/2023 |
4
| Paulson Richard A. (President and CEO) has filed a Form 4 on Karyopharm Therapeutics Inc.|
Txns:
| Sold 3,805 shares
@ $3.3516, valued at
$12.8k
|
|
| 05/04/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
| 05/04/2023 |
8-K
| Quarterly results |
| 04/24/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/05/2023 |
4
| Paulson Richard A. (President and CEO) has filed a Form 4 on Karyopharm Therapeutics Inc.|
Txns:
| Sold 3,497 shares
@ $3.97, valued at
$13.9k
|
|
| 03/31/2023 |
PRE 14A
| Form PRE 14A - Other preliminary proxy statements: |
| 03/10/2023 |
8-K
| Regulation FD Disclosure Interactive Data |
| 03/07/2023 |
4
| Paulson Richard A. (President and CEO) has filed a Form 4 on Karyopharm Therapeutics Inc.|
Txns:
| Sold 3,506 shares
@ $3.16, valued at
$11.1k
|
|
| 03/02/2023 |
4
| Rangwala Reshma (EVP & Chief Medical Officer) has filed a Form 4 on Karyopharm Therapeutics Inc.|
Txns:
| Granted 100,000 shares
@ $0 |
|
| 03/02/2023 |
4
| Poulton Stuart (EVP, Chief Development Officer) has filed a Form 4 on Karyopharm Therapeutics Inc.|
Txns:
| Granted 95,000 shares
@ $0 |
|
| 03/02/2023 |
4
| Mitchener Stephen (SVP, Chief Business Officer) has filed a Form 4 on Karyopharm Therapeutics Inc.|
Txns:
| Granted 60,000 shares
@ $0
Sold 6,357 shares
@ $3.0292, valued at
$19.3k
|
|
| 03/02/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/02/2023 |
4
| Cheng Sohanya Roshan (EVP & Chief Commercial Officer) has filed a Form 4 on Karyopharm Therapeutics Inc.|
Txns:
| Granted 100,000 shares
@ $0
Sold 11,239 shares
@ $3.0292, valued at
$34k
|
|
| 03/02/2023 |
4
| Mason Michael (EVP, CFO & Treasurer) has filed a Form 4 on Karyopharm Therapeutics Inc.|
Txns:
| Granted 95,000 shares
@ $0
Sold 11,205 shares
@ $3.0292, valued at
$33.9k
|
|
| 03/02/2023 |
4
| Paulson Richard A. (President and CEO) has filed a Form 4 on Karyopharm Therapeutics Inc.|
Txns:
| Granted 252,000 shares
@ $0
Sold 33,033 shares
@ $3.0292, valued at
$100.1k
|
|
|
|
|